Held every two years, the IAS Conference on HIV Pathogenesis, Treatment and Prevention includes many sessions on a range of HIV-related topics. Approximately 4,000 scientists, community leaders, public health experts and advocates met between June 30-July 3 in the Kuala Lumpur Convention Center.
The full conference schedule may be found on the IAS 2013 website along with a number of roadmaps that identify sessions focused on specific issues, including AIDS vaccines and biomedical prevention, treatment as prevention and towards an HIV cure.
In addition, we wanted to be sure to draw your attention to a few sessions taking place at IAS 2013 of particular interest to prevention research advocates:
Sunday, June 30
- Satellite: ARV-Based Prevention: State of the Art and Key Issues for a Multidisciplinary Research Agenda, 12:30-2:30, Mini Room 1
- Satellite: Launch of 2013 WHO Consolidated ARV Guidelines – What’s the Evidence? 14:45–16:45, Session Room 3
- Satellite: Expanding HIV Prevention Options for Women, 17:00–19:00, Mini Room 3 – Download the meeting report
Monday, July 1
- Oral Poster Session: Voluntary Medical Male Circumcision: Getting It Done, 13:00–14:00, Mini Room 1
Tuesday, July 2
- Symposium: New Approaches to Assess the Population Level Impact of New Prevention Technologies, 14:30–16:00, Session Room 3
- Symposium: HIV Vaccines and Future Strategies, 16:30–18:00, Session Room 3
Wednesday, July 3
- Late Breaker Track C: Prevention Sciences, including results of the recent Bangkok Tenofovir Study, other PrEP research, Implementing Option B+ in Malawi and the Shang Ring non-surgical VMMC device, 16:30-17:30, Session Room 1
For those not attending the conference in person, there were a number of ways to follow along at a distance. Once again NAM/AIDSMAP was the official provider of online scientific reporting from the conference. Clinical Care Options provided scientific analysis of the news announced in Kuala Lumpur. IAS provided “The Daily Bulletin” on their website with news and information from each day of the conference once the proceedings begin. You may also follow their Facebook page.